Tuesday, 2 April 2019

Taconic obtains licence to NIDDK's Wild Mouse gut microbiome

KUALA LUMPUR, April 2 (Bernama) -- Taconic Biosciences has obtained a licence to the Wild Mouse gut microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NIDDK is part of the National Institutes of Health, according to a statement.

Taconic licensed the Wild Mouse gut microbiota from NIDDK as a complement to its existing microbiome solution portfolio, which includes germ-free mice and custom microbiota associations.

“The Wild Mouse gut microbiota model will allow researchers to identify new host-microbe relationships and potential for determining new disease protection mechanisms,” said Taconic (microbiome products and services) associate director, Dr Alexander Maue.

The Wild Mouse gut microbiota can be banked for future use and/or maintained in a laboratory mouse breeding colony for immediate research purposes.

In drug discovery research, the microbiome is used to clarify the impact of varying microbiomes on the efficacy of potential therapeutics and also to potentially identify new drug targets.

By having a defined microbiome standard via the NIDDK Wild Mouse gut microbiome, customers now have a basis for comparison to better understand the microbiome of their research models.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. It provides animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide.

-- BERNAMA

No comments:

Post a Comment